Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Diabetes & Metabolism
|
April 12, 2008
Microparticles and type 2 diabetes
A S Leroyer, A Tedgui, C M Boulanger
Journal of Internal Medicine
|
April 16, 2008
Role of microparticles in atherothrombosis
A S Leroyer, A Tedgui, C M Boulanger
Annales De Cardiologie Et D'Angeiologie
|
June 27, 2008
[Circulating endothelial microparticles: a new marker of vascular injury]
C-M Boulanger, A-S Leroyer, N Amabile, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
March 30, 2011
[Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis]
F Sabatier, R Lacroix, A-S Leroyer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 2, 2013
Revisited role of microparticles in arterial and venous thrombosis
R Lacroix, C Dubois, A S Leroyer, et al.
Oncogene
|
April 12, 2016
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors
J Stalin, M Nollet, P Garigue, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Diabetes & Metabolism
|
April 12, 2008
Microparticles and type 2 diabetes
A S Leroyer, A Tedgui, C M Boulanger
Journal of Internal Medicine
|
April 16, 2008
Role of microparticles in atherothrombosis
A S Leroyer, A Tedgui, C M Boulanger
Annales De Cardiologie Et D'Angeiologie
|
June 27, 2008
[Circulating endothelial microparticles: a new marker of vascular injury]
C-M Boulanger, A-S Leroyer, N Amabile, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
March 30, 2011
[Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis]
F Sabatier, R Lacroix, A-S Leroyer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 2, 2013
Revisited role of microparticles in arterial and venous thrombosis
R Lacroix, C Dubois, A S Leroyer, et al.
Oncogene
|
April 12, 2016
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors
J Stalin, M Nollet, P Garigue, et al.
Page
of 1